Please login to the form below

Not currently logged in
Email:
Password:

AUTO1

This page shows the latest AUTO1 news and features for those working in and with pharma, biotech and healthcare.

CAR-T player Autolus seeks $100m from follow-on financing

CAR-T player Autolus seeks $100m from follow-on financing

It is earmarking $125m to continue the clinical development of its pipeline, headed by CD19-targeted CAR-T therapy AUTO1 in adult acute lymphoblastic leukaemia (ALL) – a rival to Novartis’ ... Autolus is planning a pivotal trial of AUTO1, which it

Latest news

  • Autolus’ next-gen CAR-T looks promising in ALL Autolus’ next-gen CAR-T looks promising in ALL

    Autolus is hoping that AUTO1 will change that, and its first wave of data from that programme found it compared favourably to other CAR-T therapies in adult ALL. ... For comparison purposes, Yescarta also had a 23% severe CRS rate, and a 39% grade 3

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics